Ethnic variations in paraoxonase1 polymorphism in the Malaysian population

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 2, 2007, Pages 392-397

  Poh, Rozaida ^a   Muniandy, Sekaran ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249732704     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Allebrandt KV, Souza RLR, Chautard-Freire-Maia EA. Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians, Toxicol Appl Pharmacol 2002; 180: 151-6.
2. Arca M, Ombres D, Montall A, et al. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism In an Italian population, Eur J Clin Invest 2002; 32: 9-15.
3. Arrol S, Mackness MI, Durrington PN. High-density lipoprotein associated enzymes and the prevention of low-density lipoprotein oxidation. Eur J Lab Med 1996; 4: 33-8.
4. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE, Effects of 5' regulatory region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001; 68: 1428-36.
5. Costa LG, Cole TB, Vitalone A, Furlong CE. Measurement of paraoxonase (PON1) status as a potential blomarker of susceptibility to organophosphate toxicity, Clin Chim Acta 2005; 352: 37-47.
6. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis, Arterioscler Thromb Vasc Biol 2001; 21: 473-80.
7. Hong SH, Song J, Min WK, Kim JQ. Genetic variations of the paraoxonase gene in patients with coronary artery disease. Clin Biochem 2001; 34: 475-81.
8. Hu YM, Tian HM, Liu R. Gin-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese. Diabetes Res Clin Pract 2003; 61: 21-7.
9. Ikeda Y, Suehiro T, Inoue M, et al. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus, Metabolism 1998; 47: 598-602.
10. Kao YL, Donaghue K, Chan A, Bennetts BH, Knight J, Silink M. Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes, Diab Med 2002; 19: 212-5.
11. Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H. Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene. Ann Hum Genet 2004; 68: 110-9.
12. Mackness B, Durrington P, Abuashia B, et al. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci 2000; 98: 355-63.
13. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase, Gen Pharmacol 1998; 31: 329-36.
14. Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI, Serum paraoxonase activity in type 1 diabetes compared to healthy controls. Eur J Clin Invest 2002; 32: 259-64.
15. Odawara M, Tachi Y, Yamashita K. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 19: 2257-60.
16. Phuntuwate W, Suthisisang C, Koanantakul B, Mackness MI, Mackness B. Paraoxonase 1 status in the Thai population. J Hum Genet 2005; 50: 293-300.
17. Raymond M, Rousset F. An exact test for population differentiation. Evolution 1995; 49: 1280-3.
18. Rice GI, Ossei-Gerning N, Stickland MH, Grant PJ. The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease. Coran Artery Dis 1997; 8: 677-82.
19. Richter RJ, Jampsa RL, Jarvik GP, Costa LG, Furlong CE. Determination of paraoxonase 1 status and genotypes. Curr Protocols Toxicol 2004: 4.12.1-4.12.19.
20. Ruiz J, Blanche H, James RW, et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease In type 2 diabetes. Lancet 1995; 346: 869-72.
21. Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997; 17: 1067-73.
22. Sanghera DK, Saha N, Kamboh MI, The codon 55 polymorphism in the paraoxonasel gene is not associated with the risk of coronary heart disease in Asian Indian and Chinese. Atherosclerosis 1998; 136; 217-23.
23. Santos NPC, Ribeiro-dos Santos AKC, Santos SEB. Frequency of the Q192R and L55M polymorphisms of the human serum paraoxonase gene (PON1) in ten Amazonian Amerindian tribes. Genet Mol Biol 2005; 28: 36-9.
24. Scacchi R. New data on the world distribution of paraoxonase (PON1 Gln 192-Arg) gene frequencies. Hum Biol 2003; 75: 365-73.
25. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A software for population genetics data analysis. Geneva: Genetics and Biometry Laboratory, University of Geneva, 2000.
26. Serrato M, Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995; 96: 3005-8.
27. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity 1996; 76: 377-83.
28. Yamada Y, Ando F, Nlino N, Miki T, Shimokata H. Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density In Community-Dwelling Japanese. J Hum Genet 2003; 48: 469-75.
29. Zhang Y, Zheng F, Du H, et al. Detecting the polymorphisms of paraoxonase (PON) cluster In Chinese Han population based on a rapid method. Clin Chim Acta 2006; 365: 98-103.